These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38310873)

  • 41. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.
    Tziomalos K; Athyros VG; Karagiannis A
    Curr Vasc Pharmacol; 2012 Mar; 10(2):162-72. PubMed ID: 22239625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-alcoholic fatty liver disease in Africa: a hidden danger.
    Paruk IM; Pirie FJ; Motala AA
    Glob Health Epidemiol Genom; 2019; 4():e3. PubMed ID: 31019719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonalcoholic fatty liver disease and type 2 diabetes in obese children.
    Hecht L; Weiss R
    Curr Diab Rep; 2014 Jan; 14(1):448. PubMed ID: 24277674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
    Jain V; Jana M; Upadhyay B; Ahmad N; Jain O; Upadhyay AD; Ramakrishnan L; Vikram NK
    Indian J Med Res; 2018 Sep; 148(3):291-301. PubMed ID: 30425219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
    Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
    J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type 2 Diabetes Mellitus in Class II and III Obesity: Prevalence, Associated Factors, and Correlation between Glycemic Parameters and Body Mass Index.
    Silveira EA; de Souza Rosa LP; de Carvalho Santos ASEA; de Souza Cardoso CK; Noll M
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32498226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients.
    Li F; Ye J; Sun Y; Lin Y; Wu T; Shao C; Ma Q; Liao X; Feng S; Zhong B
    Diabetes Metab J; 2021 May; 45(3):417-429. PubMed ID: 33705650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
    Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
    Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers.
    Choi YS; Klaric JS; Beltran TH
    Metab Syndr Relat Disord; 2019 Feb; 17(1):37-45. PubMed ID: 30394863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
    Chen N; Zhou J; Wang K; Li X; Li Z
    BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, NON-ALCOHOLIC FATTY LIVER DISEASE, AND ITS RELATIONSHIP WITH FRUCTOSE CONSUMPTION IN CHILDREN WITH OBESITY.
    Flores-Ramírez AG; Ibarra-Reynoso LDR; López-Lemus HL; Olvera-Juárez M; Luevano-Contreras C; Garay-Sevilla ME
    Rev Invest Clin; 2019; 71(5):339-348. PubMed ID: 31599882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy].
    Petunina NA; Telnova ME; Goncharova EV; Martirosian NS; Kuzina IA
    Ter Arkh; 2022 Nov; 94(10):1155-1162. PubMed ID: 36468989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation.
    Wang XC; Gusdon AM; Liu H; Qu S
    World J Gastroenterol; 2014 Oct; 20(40):14821-30. PubMed ID: 25356042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.